Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02747004
Title A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer (Next MONARCH 1)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company

Her2-receptor negative breast cancer


Abemaciclib + Loperamide


Abemaciclib + Tamoxifen

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

No variant requirements are available.